Navigation Links
Opioids And Abnormal Pain Perception

A growing number of animal and human studies show that under certain circumstances, opioids can elicit unexpected changes in pain sensitivity, resulting in hyperalgesia (abnormally intense pain in response to painful// stimulation) and allodynia (abnormally intense pain in response to non-painful stimulation).

Interestingly, previous studies have found evidence for hyperalgesia only subsequent to brief exposure to opioid treatment. No reports of hyperalgesia following the prolonged administration of opioids for the treatment of chronic or cancer pain have yet been published. However, using the cold pressor test (CPT), several studies have suggested that opioid addicts (OAs) may exhibit hyperalgesia as shown by their ability to maintain their hand in ice-cold water for a significantly shorter duration than were healthy controls.

Recent evidence reported on increased pain sensitivity in animals following parenteral opioid administration and in humans subsequent to intravenously of short-acting opioids and possibly in drug addicts.

A new study, to be published in Drug and Alcohol Dependence (available online 17 October 2005) was designed with the objectives to test if drug addicts, while actively consuming opioids, differ from normal subjects in their latency of pain onset, pain intensity, or time required for hand withdrawal in response to the CPT; and, if indeed so, to determine whether the discontinuation of opioid consumption will reset their altered pain responses.

For the study, 60 heroin or methadone OAs who attended a 4-week inpatient detoxification program were exposed to the cold pressor test (CPT) upon entrance to the program, at 7 and 28 days subsequent to the cessation of opioid consumption (verified by repeated urine toxicology tests). Latency of pain onset (s), pain intensity (0–100 VAS), and tolerance (time for hand withdrawal) in response to the CPT were measured. The main findings of this study were t hat in response to the CPT, OAs had a longer mean latency for pain and a lower mean pain intensity rating, in comparison with healthy controls, whereas their mean time for hand withdrawal (tolerance) was shorter than that of the controls. In addition, their altered pain perception did not reset 4 weeks subsequent to the cessation of opioid use. The present study provides further evidence that OAs exhibit short tolerance to the CPT, as manifested by their quicker hand withdrawal, which can be interpreted as hyperalgesia.
'"/>




Related medicine news :

1. Back pain treated with Opioids
2. Opioids Linked to Worse Outcomes After Back Injury
3. Prescription Opioids Abused More Than Heroin - A Report Says
4. Early Detection Of Facial Abnormalities in a Fetus
5. Abnormal Brain Structure One Of The Reasons For Depression in Adolescents
6. Antidepressants Could Lead To Abnormal Bleeding
7. Abnormal heart rate and depression may increase death risk
8. Cancer Causing Proteins Trigger Abnormal Biochemical Reactions In Cells
9. Neglect In Childhood Could Cause Abnormal Behaviour In Adults
10. Detecting Brain Abnormalities in Babies Using New Brain Scanners.
11. New Abnormal Karyotypes Discovered in China
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/12/2017)... PALM CITY, Fla. (PRWEB) , ... October 12, 2017 , ... ... of cold therapy products, announced today the introduction of an innovative new design of ... the multipurpose pad so you get maximum comfort while controlling your pain while using ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... delivery system that we intend to develop to enable prevention of a major ... to severe hearing loss, especially in pediatric patients. For cisplatin, hearing loss is ...
(Date:10/12/2017)... ... 12, 2017 , ... Leading pediatric oncology experts at Children’s National Health ... Congress of the International Society of Paediatric Oncology (SIOP) Oct. 12-15. Chaired ... Cancer and Blood Disorders at Children’s National, and Stephen P. Hunger, M.D., Chief ...
(Date:10/12/2017)... ... October 12, 2017 , ... Health Literacy ... health literacy software tool, and the Cancer Patient Education Network (CPEN), an independent ... today announce a new strategic alliance. , As CPEN’s strategic partner, HLI ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... of California Berkeley, and other leading institutions in announcing the launch of the ... to change the way animals are raised for food. , Founding members of ...
Breaking Medicine News(10 mins):
(Date:9/25/2017)... , Sept. 25, 2017  EpiVax, Inc., ... vaccine design, and immune-engineering today announced the launch ... the development of personalized therapeutic cancer vaccines. EpiVax ... provided exclusive access to enabling technologies to the ... MBA will lead EpiVax Oncology as Chief Executive ...
(Date:9/19/2017)... Inc., a venture-backed medical device company developing a non-invasive, robotically assisted, platform therapy that uses ... today:   ... Jim ... Tom Tefft ... Veteran medical device executive Josh Stopek , PhD, who has led R&D and business ...
(Date:9/13/2017)... Sept. 13, 2017   OrthoAtlanta has been named ... Football Host Committee (AFHC) for the 2018 College Football Playoff ... 2018, at Mercedes-Benz Stadium in Atlanta, Georgia ... AFHC "I,m In" campaign, participating in many activities leading up ... ...
Breaking Medicine Technology: